Featured Research

from universities, journals, and other organizations

Immune Reaction At Tumour Site Determines Clinical Outcome In Patients With Colorectal Cancer

Date:
September 15, 2009
Source:
Deutsche Gesellschaft fuer Immunologie e.V./German Society for Immunology
Summary:
The immune reaction at tumour site determines cancer evolution and clinical outcome in patients with colorectal cancer, regardless of the local extent and spread of the tumour, according to new findings. The analysis of immunological parameters should therefore be integrated into the process of staging and clinical decision finding, one of the researchers says.

The immune reaction at tumour site determines cancer evolution and clinical outcome in patients with colorectal cancer, regardless of the local extent and spread of the tumour, according to the findings of Jιrτme Galon, INSERM Research Director, Paris, and co-workers. The analysis of immunological parameters should therefore be integrated into the process of staging and clinical decision finding, says Galon at the 2nd European Congress of Immunology ECI 2009.

Related Articles


Colorectal cancer is one of the most common malignancies, with an estimated annual incidence of one million cases worldwide. The prognosis is severe, with a 5-year-survival of 55 %. Surgical resection is effective for localized disease. An additional post-surgical course of chemotherapy is reserved for patients with lymph node or distant metastases. But also a significant proportion of patients with local disease (Stage I/II patients) develops recurrence and dies from the disease. “There is clearly a need to identify novel predictive factors to identify patients with the potential for colon cancer progression,” Galon stresses.

Actually, assessing patient survival and choosing the optimal therapy are based on the currently used classification. Staging includes tumour size, local spread and distant metastases. Galon und co-workers showed that a detailed analysis of local immune reaction would be a better predictor, especially in identifying high risk patients with minimal invasive tumours.

Galon analysed the infiltration of lymphocytes, the most important cells of immune response, into the tumour and peritumoural tissue in 415 patients with colorectal cancer. The scientist developed a comprehensive analysis of the nature, the functional orientation, the density and the organization of the immune cell populations within the tumour. He performed a large-scale analysis of in situ immune parameters as well as an original analysis of gene expression, which enables the identification of genes whose co-expression is correlated with cancer evolution. These data were confirmed in a blinded manner in two independent patient cohorts (n= 60 and n= 119) from different hospitals.

All statistical analyses reveal the strength of the in situ immune contexture on clinical outcome at all stages of the disease. High density of immune cells correlated with an equally favourable prognosis regardless of the cancer size and spread. Conversely, a weak immune response correlated with a very poor prognosis even in patients with minimal tumour invasion. "This has never been shown in any human tumour“, says Galon. As a consequence this should lead to recast the currently used classification of colorectal cancers for predicting clinical outcome, and refine the patient groups that are at high-risk of tumour recurrence that may benefit from adjuvant theapy, including immunotherapy.

Recent data of 602 stage I-II patients with colorectal cancer from two independent cohorts emphasize the crucial role of two T cell populations: the cytotoxic (CD8) and the memory T cells. Memory T cells obviously control the early steps of the metastatic process. They may have a central role in the control of tumour spreading along lymphovascular and perineural structures, but also to lymph nodes or distant organs. The function of these immune cells is relevant for the recurrence risk and patient survival, even in very small tumours. Galon und colleagues developed a simple "immune score“ method, which may be of clinical value for the identification of high-risk patients.


Story Source:

The above story is based on materials provided by Deutsche Gesellschaft fuer Immunologie e.V./German Society for Immunology. Note: Materials may be edited for content and length.


Cite This Page:

Deutsche Gesellschaft fuer Immunologie e.V./German Society for Immunology. "Immune Reaction At Tumour Site Determines Clinical Outcome In Patients With Colorectal Cancer." ScienceDaily. ScienceDaily, 15 September 2009. <www.sciencedaily.com/releases/2009/09/090915101639.htm>.
Deutsche Gesellschaft fuer Immunologie e.V./German Society for Immunology. (2009, September 15). Immune Reaction At Tumour Site Determines Clinical Outcome In Patients With Colorectal Cancer. ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2009/09/090915101639.htm
Deutsche Gesellschaft fuer Immunologie e.V./German Society for Immunology. "Immune Reaction At Tumour Site Determines Clinical Outcome In Patients With Colorectal Cancer." ScienceDaily. www.sciencedaily.com/releases/2009/09/090915101639.htm (accessed October 30, 2014).

Share This



More Health & Medicine News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Reuters - Innovations Video Online (Oct. 29, 2014) — A Swedish amputee who became the first person to ever receive a brain controlled prosthetic arm is able to manipulate and handle delicate objects with an unprecedented level of dexterity. The device is connected directly to his bone, nerves and muscles, giving him the ability to control it with his thoughts. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Google To Use Nanoparticles, Wearables To Detect Disease

Google To Use Nanoparticles, Wearables To Detect Disease

Newsy (Oct. 29, 2014) — Google X wants to improve modern medicine with nanoparticles and a wearable device. It's all an attempt to tackle disease detection and prevention. Video provided by Newsy
Powered by NewsLook.com
Can Drinking Milk Lead To Early Death?

Can Drinking Milk Lead To Early Death?

Newsy (Oct. 29, 2014) — Researchers in Sweden released a study showing heavy milk drinkers face an increased mortality risk from a variety of causes. Video provided by Newsy
Powered by NewsLook.com
Obama: The US Will Not 'run and Hide' From Ebola

Obama: The US Will Not 'run and Hide' From Ebola

AP (Oct. 29, 2014) — Surrounded by health care workers in the White House East Room, President Barack Obama said the U.S. will likely see additional Ebola cases in the weeks ahead. But he said the nation can't seal itself off in the fight against the disease. (Oct. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:  

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile iPhone Android Web
    Follow Facebook Twitter Google+
    Subscribe RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins